Literature DB >> 1380626

Transmission of Pseudomonas cepacia among cystic fibrosis patients.

L Millar-Jones, A Paull, Z Saunders, M C Goodchild.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1380626     DOI： 10.1016/0140-6736(92)91817-r

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients.

Authors:  T Mann; D Ben-David; A Zlotkin; D Shachar; N Keller; A Toren; A Nagler; G Smollan; A Barzilai; G Rahav
Journal:  Infection       Date:  2010-04-01       Impact factor: 3.553

3.  Isolation of Burkholderia cepacia by enrichment.

Authors:  P G Flanagan; A Paull
Journal:  J Clin Pathol       Date:  1998-07       Impact factor: 3.411

Review 4.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

5.  Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis.

Authors:  G R Hutchinson; S Parker; J A Pryor; F Duncan-Skingle; P N Hoffman; M E Hodson; M E Kaufmann; T L Pitt
Journal:  J Clin Microbiol       Date:  1996-03       Impact factor: 5.948

Review 6.  Epidemiology, Biology, and Impact of Clonal Pseudomonas aeruginosa Infections in Cystic Fibrosis.

Authors:  Michael D Parkins; Ranjani Somayaji; Valerie J Waters
Journal:  Clin Microbiol Rev       Date:  2018-08-29       Impact factor: 26.132

7.  Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission.

Authors:  D L Smith; L B Gumery; E G Smith; D E Stableforth; M E Kaufmann; T L Pitt
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

Review 8.  Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Authors:  J R Govan; V Deretic
Journal:  Microbiol Rev       Date:  1996-09

9.  Outcome for patients colonised with Burkholderia cepacia in a Birmingham adult cystic fibrosis clinic and the end of an epidemic.

Authors:  K Muhdi; F P Edenborough; L Gumery; S O'Hickey; E G Smith; D L Smith; D E Stableforth
Journal:  Thorax       Date:  1996-04       Impact factor: 9.139

10.  Clinical outcome after acquisition of Burkholderia cepacia in patients with cystic fibrosis.

Authors:  M McCloskey; J McCaughan; A O Redmond; J S Elborn
Journal:  Ir J Med Sci       Date:  2001 Jan-Mar       Impact factor: 2.089
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.